FINANCIAL SUPPORT FOR PATIENTS
We’re committed to ensuring access to ENVARSUS XR. Whatever your patient’s insurance or financial situation, we’ve got it covered. Our dedicated financial support covers patients with commercial or government insurance, or those who are uninsured/underinsured.
Free 30-day trial*
To switch a patient without waiting for the results of a benefits investigation, start a 30-day free trial today. Start your patients on ENVARSUS XR immediately, at no cost.
$0 Co-pay card†
Out-of-pocket savings for eligible commercially insured patients. For patients with insurance coverage for ENVARSUS XR, the $0 Co-pay card offers significant savings.
Patient Assistance Program (PAP)‡
Provides free ENVARSUS XR for eligible patients in need who meet certain criteria. Follow these steps to find out if your patients qualify for the PAP.
Call 1-844-VELOXIS to enroll
Your practice or patient calls 1-844-VELOXIS (835-6947) and selects the appropriate phone prompt for Veloxis Transplant Support (press 3). The phone prompt will direct the caller to a financial support representative who will review the process and guidelines for PAP eligibility.
Complete the Veloxis Transplant Support enrollment form
The applicant will be instructed to fill out the Veloxis Transplant Support enrollment form, including patient and insurance information. The patient will be required to sign and date the form.§
Veloxis Transplant Support will conduct a benefits investigation to determine patient eligibility
Eligibility for PAP is determined on a per-patient basis, so time to approval may vary. A 30-day free trial voucher is available for all patients, regardless of eligibility, who may require a longer benefits investigation.
Approved patients will receive an initial 90-day supply of medication and remain eligible for up to 1 year
Accepted PAP patients are eligible for up to 1 year from notice of approval. All approved patients will be sent a 90-day supply of medication, which will be shipped directly to the patient or healthcare provider. A new Veloxis Transplant Support enrollment form is required for approved patients re-applying to the PAP after 1 year.
Verify coverage, identifying possible restrictions, and reporting cost sharing by tier.
Prior authorization assistance
Guides you through every step of a payer’s process, identifying requirements, and providing templates for statements of medical necessity.
Alternative funding research
Identifies independent foundations that can assist patients who are underinsured or uninsured.
Coordination with specialty pharmacies
Ensures access to ENVARSUS XR prior to filling prescriptions.
Prescription fulfillment navigation
Identifies the most cost-effective method to fill ENVARSUS XR prescriptions.
Eligible insured patients can save up to a maximum benefit of $8,550 annually off the patient’s co-pay or out-of-pocket expenses of ENVARSUS XR. Patient is responsible for any differential over $8,550. This offer can be used an unlimited number of times. Offer not valid for cash paying patients or where drug is not covered by the primary insurance. This offer is valid in the United States. No substitutions permitted. Offer not valid for prescriptions reimbursed under Medicaid, a Medicare drug benefit plan, Tricare, or other federal or state health programs (such as medical assistance programs).
Please call your Specialist to see if your patient will qualify for Patient Assistance (free medication). This offer is not insurance and is not valid for mail order. Quantity limits may apply.
Hard copy prescription required for the state of New York..
What makes ENVARSUS XR different from other formulations? Explore the publications about ENVARSUS XR